ID: ALA3867191
Type: ADME
Description: Reversible inhibition of CYP2C9 in human liver microsomes using (S)-warfarin as substrate in presence of NADPH by LC-MS/MS analysis
Organism: Homo sapiens
Tissue: Liver
Subcellular Fraction: Microsomes
Bioactivity
Activity Types for Assay ALA3867191
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
371.87 | 4.21 | 4.21 |
391.52 | 3.93 | 3.93 |
402.48 | 1.96 | 1.96 |
367.43 | 3.24 | 3.24 |
429.55 | 2.17 | 2.17 |
381.46 | 3.54 | 3.54 |
382.45 | 2.82 | 2.82 |
392.44 | 3.59 | 3.59 |
393.47 | 3.14 | 3.14 |
408.48 | 2.72 | 2.72 |
408.48 | 2.84 | 2.84 |
399.52 | 3.41 | 3.41 |
427.43 | 3.60 | 3.60 |
427.43 | 3.38 | 3.38 |
378.45 | 3.66 | 3.66 |
460.44 | 3.74 | 3.74 |
429.40 | 3.26 | 3.26 |
425.47 | 2.76 | 2.76 |
426.56 | 2.94 | 2.94 |
329.38 | 1.90 | 1.90 |
407.45 | 3.17 | 3.17 |
372.47 | 3.33 | 3.33 |
386.50 | 3.14 | 3.14 |
406.49 | 1.77 | 1.77 |
413.41 | 3.60 | 3.60 |
401.53 | 4.06 | 4.06 |
412.53 | 2.55 | 2.55 |
398.49 | 3.18 | 3.18 |
428.49 | 3.77 | 3.77 |
398.51 | 2.16 | 2.16 |
416.52 | 2.77 | 2.77 |
487.65 | 3.86 | 3.86 |
400.48 | 2.13 | 2.13 |
386.50 | 3.14 | 3.14 |
408.51 | 2.09 | 2.09 |
385.46 | 3.59 | 3.59 |
425.56 | 3.12 | 3.12 |
370.50 | 2.78 | 2.78 |
385.51 | 2.72 | 2.72 |
384.48 | 3.10 | 3.10 |
412.53 | 2.29 | 2.29 |
217.27 | 1.95 | 1.95 |
348.41 | 2.73 | 2.73 |
372.47 | 2.75 | 2.75 |
405.50 | 2.75 | 2.75 |
410.44 | 3.08 | 3.08 |
428.53 | 3.49 | 3.49 |
398.51 | 3.29 | 3.29 |
386.50 | 3.14 | 3.14 |
422.53 | 2.40 | 2.40 |
372.47 | 3.33 | 3.33 |
409.49 | 2.65 | 2.65 |
390.53 | 3.45 | 3.45 |
330.37 | 1.14 | 1.14 |
374.49 | 2.92 | 2.92 |
257.34 | 2.87 | 2.87 |
384.52 | 3.17 | 3.17 |
426.56 | 2.94 | 2.94 |
385.47 | 2.50 | 2.50 |
408.51 | 2.09 | 2.09 |
358.44 | 2.37 | 2.37 |
251.29 | 2.49 | 2.49 |
384.48 | 3.33 | 3.33 |
400.48 | 2.13 | 2.13 |
390.49 | 3.05 | 3.05 |
404.50 | 2.13 | 2.13 |
442.45 | 3.19 | 3.19 |